Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Citigroup Maintains Buy on Walmart, Raises Price Target to $179

Citigroup analyst Paul Lejuez maintains Walmart (NYSE:WMT) with a Buy and raises the price target from $172 to $179.

Citigroup analyst Paul Lejuez maintains Walmart (NYSE:WMT) with a Buy and raises the price target from $172 to $179.

Total
0
Shares
Related Posts
Read More

GBT Presented Positive New Data on Oxbryta (voxelotor) in Patients with Sickle Cell Disease at ASH 2021; Said Real-world Experience Study of More Than 3,100 Patients Demonstrates Statistically Significant Reductions in Transfusions, Vaso-occlusive Cris…

lobal Blood Therapeutics, Inc. (GBT) (NASDAQ: GBT) today announced positive results from real-world and long-term studies with Oxbryta® (voxelotor) tablets for the treatment of sickle cell disease (SCD).

GBT